Navigation Links
ConvaTec Announces Acquisition of Boston Medical Device
Date:9/1/2011

SKILLMAN, N.J., Sept. 1, 2011 /PRNewswire/ -- ConvaTec Inc., a world-leading developer and marketer of innovative medical technologies for community and hospital care today announced that the company has acquired Boston Medical Device, Inc. (BMD), a distribution company that offers a platform of specialized medical devices throughout Latin America.

More than 30 years of management experience building relationships in key Latin American markets, coupled with strong market share in both wound and ostomy care products, have enabled BMD to maintain market leadership and positions the company well for growth and expansion.  BMD is the current exclusive distributor of ConvaTec products for Latin America, making it an ideal complement to ConvaTec as the company continues to pursue growth in emerging markets.

"Emerging markets, particularly Latin America, are an increasingly important growth component for ConvaTec," stated Nino Pionati, President, ConvaTec Intercontinental. "Today's announcement is a reflection of that strategic priority as well as recognition of the market leadership that BMD has achieved and maintained in this region over the years."

"BMD is excited to become part of the ConvaTec family and to be able to work even more closely with ConvaTec to continually provide the quality products and services our customers have come to expect, and that the patients who use our products on a daily basis deserve," stated Erich Roht, President and CEO, BMD.

In keeping with our commitment to our customers, there will be no impact on current orders and delivery schedules. Business will continue as normal and both companies are committed to ensuring our customers and their patients continue to receive the ConvaTec products that they have come to know and trust.

About ConvaTec Inc.ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.

About Boston Medical Device, Inc. Boston Medical Device, Inc. (BMD) is a leading promoter and distributor of specialized medical devices and related healthcare products and services on a Pan-Latin America basis. The Company has wholly owned subsidiaries across Latin American that focuses their efforts on sales, marketing and distribution. BMD has more than 170 employees in nine countries across Latin America.Media Contact:Investor Relations Contact:Nimisha SavaniTim Winston1-908-904-25221-908-904-2988mediarelations@convatec.com

investorrelations@convatec.com
'/>"/>

SOURCE ConvaTec Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ConvaTec Healthcare Announces 2011 Second Quarter Earnings Call
2. ConvaTec Announces Asia-Pacific Leadership Appointments
3. Preliminary Results of a Large Scale Study Show ConvaTec Moldable Technology™ Skin Barriers Help to Prevent and Improve Peristomal Skin Issues in Ostomy Patients
4. ConvaTec Healthcare Announces 2011 First Quarter Earnings Call
5. ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
6. ConvaTec Announces Acquisition of Trent Direct
7. ConvaTec Healthcare Announces 2010 Year-End Earnings Call
8. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
9. Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care
10. ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans
11. ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... 19, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... for the treatment of grievous blood-based disorders with significant ... be presented in a poster session at the European ... Copenhagen . The presentations will include additional ... sickle cell disease (SCD), including 90-day data from a ...
(Date:5/19/2016)... , May 19, 2016  IBM,s (NYSE:   IBM )  ... study to identify drug candidates to cure Zika, a ... declared a global public health emergency. IBM ... with a computer or Android device to join the ... or money to help; they simply  run an app ...
(Date:5/18/2016)... 19, 2016 Global ... Report initially provides a basic overview of ... manufacturing technology, post which the report explores ... the market. Complete report on ... providing 8 company profiles and 98 tables ...
Breaking Medicine Technology:
(Date:5/23/2016)... ... May 23, 2016 , ... California State University Northridge ... quality of life and is currently focusing on ways to improve how people ... tested through research to find out whether watching them could have a significant ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... on its Chesterfield, Missouri, campus, Standard Process Inc. awarded $6,000 in ... Siewert and Chloe Tillman. Each student is in her fifth trimester of classes ...
(Date:5/23/2016)... ... 2016 , ... Hospice of Westchester (HOW), an organization which ... years, recently hosted its sixth annual Celebration of Life Memorial Butterfly Release. Hundreds ... concluding with the release of Monarch butterflies that honored the memories of loved ...
(Date:5/23/2016)... ... May 23, 2016 , ... Bio-Optronics, Inc. is delighted to ... of its recent and anticipated growth. , Max Elbaz was appointed as Vice ... market segments. Max joined the Bio-Optronics team in March. His areas of expertise ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... address the nation’s prescription opioid epidemic (1), physicians are not legally required to ... at the state level (2, 3, 4). Novus Medical Detox Center , ...
Breaking Medicine News(10 mins):